Our Technology

Non-coding regulatory RNAs such as MicroRNA, Small Nucleolar RNA, Circular RNA, etc. play a critical role in regulating gene expression and have emerged as valuable biomarkers for predicting the onset and progression of various diseases, including cancers. These small RNA molecules can be detected in blood samples through liquid biopsy, providing a minimally invasive method to monitor disease dynamics in real-time. By analyzing specific patterns of regulatory molecules, clinicians can gain insights into the early stages of disease development and track how it evolves over time. This allows for timely interventions and personalized treatment strategies, enhancing patient outcomes and offering a new frontier in precision medicine.